Annual Gross Margin
N/A
31 December 2023
Summary:
Protagenic Therapeutics annual gross profit margin is not available.PTIX Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
N/A
30 September 2024
Summary:
Protagenic Therapeutics quarterly gross profit margin is not available.PTIX Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTIX Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PTIX Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Protagenic Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | -5.50%(-80.8%) |
| June 2011 | - | -28.66%(+115.2%) |
| Mar 2011 | - | -13.32%(-65.7%) |
| Dec 2010 | -6.70%(-130.4%) | -38.81%(-1956.9%) |
| Sept 2010 | - | 2.09%(-169.7%) |
| June 2010 | - | -3.00%(-174.1%) |
| Mar 2010 | - | 4.05%(-86.7%) |
| Dec 2009 | 22.03%(-15.2%) | 30.37%(+244.7%) |
| Sept 2009 | - | 8.81%(-62.0%) |
| June 2009 | - | 23.16%(-6.3%) |
| Mar 2009 | - | 24.71%(-177.1%) |
| Dec 2008 | 25.99%(-69.9%) | -32.05%(-202.9%) |
| Sept 2008 | - | 31.16%(-25.0%) |
| June 2008 | - | 41.57%(-16.2%) |
| Mar 2008 | - | 49.59%(-44.9%) |
| Dec 2007 | 86.44%(-10.7%) | 90.05%(+4.0%) |
| Sept 2007 | - | 86.60%(+10.6%) |
| June 2007 | - | 78.33%(-10.1%) |
| Mar 2007 | - | 87.13%(-10.9%) |
| Dec 2006 | 96.81% | - |
| Apr 2006 | - | 97.81%(+114.0%) |
| Apr 2003 | - | 45.70%(-4.2%) |
| Jan 2003 | - | 47.69%(+14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2002 | - | 41.70%(+4.0%) |
| July 2002 | 43.21%(-0.1%) | 40.10%(-12.5%) |
| Apr 2002 | - | 45.84%(+2.1%) |
| Jan 2002 | - | 44.88%(+6.6%) |
| Oct 2001 | - | 42.12%(+16.7%) |
| July 2001 | 43.27%(-3.6%) | 36.10%(-16.1%) |
| Apr 2001 | - | 43.03%(-9.0%) |
| Jan 2001 | - | 47.28%(+0.3%) |
| Oct 2000 | - | 47.13%(+177.2%) |
| July 2000 | 44.90%(+7.9%) | 17.00%(-70.7%) |
| Apr 2000 | - | 57.93%(+9.7%) |
| Jan 2000 | - | 52.83%(-8.9%) |
| Oct 1999 | - | 57.98%(-2942.2%) |
| July 1999 | 41.60%(-16.9%) | -2.04%(-103.3%) |
| Apr 1999 | - | 61.78%(+6.9%) |
| Jan 1999 | - | 57.78%(-0.9%) |
| Oct 1998 | - | 58.33%(+180.8%) |
| July 1998 | 50.04%(-9.9%) | 20.77%(-66.6%) |
| Apr 1998 | - | 62.22%(-0.4%) |
| Jan 1998 | - | 62.50%(+8.7%) |
| Oct 1997 | - | 57.50%(-3.0%) |
| July 1997 | 55.56% | 59.26%(+9.6%) |
| Apr 1997 | - | 54.05%(-2.0%) |
| Jan 1997 | - | 55.17% |
FAQ
- What is the all time high annual gross margin for Protagenic Therapeutics?
- What is the all time high quarterly gross margin for Protagenic Therapeutics?
What is the all time high annual gross margin for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual gross profit margin is 96.81%
What is the all time high quarterly gross margin for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly gross profit margin is 97.81%